Oncolytics Biotech Inc. (ONCY)

Oncolytics Biotech Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.94	34.91	11.67	41.26	31.22
Short-Term Investments	-	-	20.47	-	-
Cash & Short-Term Investments	15.94	34.91	32.14	41.26	31.22
Cash Growth	-54.34%	8.63%	-22.11%	32.17%	120.66%
Other Receivables	0.07	0.02	0.03	0.08	0.09
Receivables	0.07	0.02	0.03	0.08	0.09
Prepaid Expenses	1.89	3.25	1.7	2.78	2.43
Other Current Assets	0.98	-	1.82	0.78	-
Total Current Assets	18.88	38.17	35.68	44.9	33.74
Property, Plant & Equipment	1.31	0.65	0.65	0.98	0.61
Other Long-Term Assets	-	-	1	-	-
Total Assets	20.19	38.82	37.33	45.88	34.35
Accounts Payable	1.09	1.08	2.25	0.59	1.81
Accrued Expenses	3.71	2.49	1.4	1.39	-
Current Portion of Leases	0.28	0.13	0.22	0.29	0.25
Other Current Liabilities	1.62	0.53	0.08	0.41	0.66
Total Current Liabilities	6.69	4.24	3.95	2.69	2.71
Long-Term Leases	0.79	0.29	0.16	0.36	0.15
Long-Term Unearned Revenue	6.73	6.73	6.73	6.73	6.73
Total Liabilities	14.2	11.26	10.83	9.78	9.59
Common Stock	438.19	430.91	404.04	391.35	356.82
Additional Paid-In Capital	44.54	42.12	40.05	34.16	31.02
Retained Earnings	-477.71	-446	-418.25	-393.42	-367.11
Comprehensive Income & Other	0.96	0.54	0.66	4.01	4.02
Shareholders' Equity	5.98	27.56	26.5	36.1	24.75
Total Liabilities & Equity	20.19	38.82	37.33	45.88	34.35
Total Debt	1.06	0.42	0.37	0.66	0.4
Net Cash (Debt)	14.88	34.49	31.77	40.61	30.82
Net Cash Growth	-56.86%	8.58%	-21.77%	31.77%	125.91%
Net Cash Per Share	0.19	0.51	0.55	0.76	0.76
Filing Date Shares Outstanding	86.42	75.42	62.83	57.11	52.08
Total Common Shares Outstanding	80.02	74.42	61.33	55.04	46.17
Working Capital	12.19	33.94	31.74	42.21	31.03
Book Value Per Share	0.07	0.37	0.43	0.66	0.54
Tangible Book Value	5.98	27.56	26.5	36.1	24.75
Tangible Book Value Per Share	0.07	0.37	0.43	0.66	0.54
Machinery	0.86	0.75	0.74	0.69	0.78
Leasehold Improvements	0.18	0.23	0.23	0.23	0.5

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q